Search results
PIELD Study
Author(s):
Ganapathi Palaniappan
,
Rhuban M Sundran
,
Afif Ashari
,
et al
Added:
1 year ago
Article
Author(s):
Hartika Safitri
,
Amir Aziz Alkatiri
,
Doni Firman
,
et al
Added:
8 months ago
Author(s):
Barbara Stähli
Added:
7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275).
MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST…
View more
Author(s):
Paul Jie Wen Tern
,
Yilin Jiang
,
Yee How Lau
,
et al
Added:
2 years ago
Use of MCS in CHIP
Author(s):
Jonathan Gabriel Sung
,
Ho Lam
,
Chui Ka-Lung
,
et al
Added:
4 months ago
Article
Author(s):
Wan Azman Wan Ahmad
,
Edouard Benit
,
Cyril Camaro
,
et al
Added:
1 year ago
Author(s):
Khung Keong Yeo
,
Ryuji Fukazawa
,
Mamoru Ayusawa
,
et al
Added:
6 months ago
Author(s):
Joo-Yong Hahn
Added:
1 year ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions …
View more
Author(s):
Arjun K Ghosh
,
Deepak L Bhatt
,
Cezar Iliescu
Added:
2 years ago
Cardio-oncology topic editor, Dr Arjun Ghosh (University College London Hospital and Hatter Cardiovascular Institute, UK) is joined by Dr. Deepak L. Bhatt (Brigham and Women's Hospital, Medical School, US) and Dr Cezar Iliescu(The University of Texas MD Anderson Cancer Center, US) to discuss interventional issues in cancer patients with a focus on patients with acute coronary syndromes (ACS)…
View more
Author(s):
Davide Cao
Added:
2 years ago
Dr Davide Cao (Icahn School of Medicine at Mount Sinai, US) discusses the key results and impact on clinical practice of the pre-specified analysis of the TWILIGHT trial presented at ESC Congress 2021.
TWILIGHT-HBR evaluated the effects of ticagrelor monotherapy versus ticagrelor (Brilinta) plus aspirin on bleeding and ischemic outcomes in a contemporary ARC-defined HBR population undergoing…
View more